First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial

• DOI: 10.1200/jco.23.01601
• Publication Date: 2024-02-21T21:00:57Z
• Authors: Yelena Y. Janjigian; Jaffer A. Ajani; Markus Moehler; Lin Shen; Marcelo Garrido; Carlos Gallardo; Lucjan Wyrwicz; Kensei Yamaguchi; James M. Cleary; Elena Elimova; Michalis Karamouzis; Ricardo Bruges; Tomasz Skoczylas; Arinilda Bragagnoli; Tianshi Liu; Mustapha Tehfe; Thomas Zander; Ruben Kowalyszyn; Roberto Pazo-Cid; Michael Schenker; Kynan Feeny; Rui Wang; Ming Lei; Clara Chen; Raheel Nathani; Kohei Shitara
• Keywords: Esophageal adenocarcinoma; Gastric adenocarcinoma

JCO